Mechanisms and management of crizotinib-induced toxicity in non-small cell lung cancer

Puntos clave

• Crizotinib-induced toxicity affects treatment outcomes in non-small cell lung cancer, necessitating targeted management strategies.
• Key findings highlight specific biomarkers that can predict and manage toxicity, ensuring safer therapy.
• The overview includes mechanisms of toxicity related to crizotinib, emphasizing pathways involved in adverse effects.
• Understanding toxicity management of crizotinib may enable better treatment protocols, improving patient experiences.